Oxford Drug Design reports major in vivo milestone for novel cancer therapy 12 Jan Written by Alexandra Collingbourne Alexandra Collingbourne Previous Previous CyberSmart joins NCRCG to support SMEs and MSPs Next Next Qureight appoints Rebecca Simmons as Chief Operating Officer
Oxford Drug Design reports major in vivo milestone for novel cancer therapy 12 Jan Written by Alexandra Collingbourne Alexandra Collingbourne
